Por favor, use este identificador para citar o enlazar a este item: http://hdl.handle.net/10261/8393
COMPARTIR / EXPORTAR:
logo share SHARE logo core CORE BASE
Visualizar otros formatos: MARC | Dublin Core | RDF | ORE | MODS | METS | DIDL | DATACITE

Invitar a revisión por pares abierta
Campo DC Valor Lengua/Idioma
dc.contributor.authorGrande-Pérez, Ana-
dc.contributor.authorLázaro, Ester-
dc.contributor.authorLowenstein, Pedro R.-
dc.contributor.authorDomingo, Esteban-
dc.contributor.authorManrubia Cuevas, Susanna-
dc.date.accessioned2008-11-10T16:07:46Z-
dc.date.available2008-11-10T16:07:46Z-
dc.date.issued2005-03-14-
dc.identifier.citationPNAS 102 (12): 4448-4452 (2005)en_US
dc.identifier.issn0027-8424-
dc.identifier.urihttp://hdl.handle.net/10261/8393-
dc.description.abstractRNA viruses replicate with a very high error rate and give rise to heterogeneous, highly plastic populations able to adapt very rapidly to changing environments. Viral diseases are thus difficult to control because of the appearance of drug-resistant mutants, and it becomes essential to seek mechanisms able to force the extinction of the quasispecies before adaptation emerges. An alternative to the use of conventional drugs consists in increasing the replication error rate through the use of mutagens. Here, we report about persistent infections of lymphocytic choriomeningitis virus treated with fluorouracil, where a progressive debilitation of infectivity leading to eventual extinction occurs. The transition to extinction is accompanied by the production of large amounts of RNA, indicating that the replicative ability of the quasispecies is not strongly impaired by the mutagen. By means of experimental and theoretical approaches, we propose that a fraction of the RNA molecules synthesized can behave as a defective subpopulation able to drive the viable class extinct. Our results lead to the identification of two extinction pathways, one at high amounts of mutagen, where the quasispecies completely loses its ability to infect and replicate, and a second one, at lower amounts of mutagen, where replication continues while the infective class gets extinct because of the action of defectors. The results bear on a potential application of increased mutagenesis as an antiviral strategy in that low doses of a mutagenic agent may suffice to drive persistent virus to extinctionen_US
dc.description.sponsorshipThis work was supported by a Sir Henry Welcome Award for Innovative Research, The Wellcome Trust (P.L. and E.D.), an International Research Collaboration grant from The Wellcome Trust, the British Heart Foundation, and the National Health Service research and development levy. Work in Madrid was supported by BioMed Central, Comunidad Autónoma de Madrid, and Fundación Ramón Areces grants (to E.D.). A.G.-P. was supported by Consejería de Educación (Comunidad Autónoma de Madrid). A.G.-P. and S.C.M. were supported by Ramón y Cajal contracts from the Ministerio de Ciencia y Tecnología. Work at Centro de Astrobiología was supported by the Instituto Nacional de Técnica Aeroespacialen_US
dc.format.extent325970 bytes-
dc.format.mimetypeapplication/pdf-
dc.language.isoengen_US
dc.publisherNational Academy of Sciences (U.S.)en_US
dc.rightsopenAccessen_US
dc.subjectError catastropheen_US
dc.subjectRNA virusen_US
dc.subjectReplicative abilityen_US
dc.titleSuppression of viral infectivity through lethal defectionen_US
dc.typeartículoen_US
dc.identifier.doi10.1073/pnas.0408871102-
dc.description.peerreviewedPeer revieweden_US
dc.relation.publisherversionhttp://dx.doi.org/10.1073/pnas.0408871102en_US
dc.identifier.e-issn1091-6490-
dc.contributor.funderWellcome Trust-
dc.contributor.funderBritish Heart Foundation-
dc.contributor.funderNational Health Service (UK)-
dc.contributor.funderBioMed Central-
dc.contributor.funderComunidad de Madrid-
dc.contributor.funderFundación Ramón Areces-
dc.contributor.funderMinisterio de Ciencia y Tecnología (España)-
dc.contributor.funderInstituto Nacional de Técnica Aeroespacial (España)-
dc.identifier.funderhttp://dx.doi.org/10.13039/100004440es_ES
dc.identifier.funderhttp://dx.doi.org/10.13039/501100000274es_ES
dc.identifier.funderhttp://dx.doi.org/10.13039/100008054es_ES
dc.identifier.funderhttp://dx.doi.org/10.13039/501100006280es_ES
dc.identifier.funderhttp://dx.doi.org/10.13039/100012818es_ES
dc.identifier.funderhttp://dx.doi.org/10.13039/501100010687es_ES
dc.identifier.pmid15767582-
dc.type.coarhttp://purl.org/coar/resource_type/c_6501es_ES
item.cerifentitytypePublications-
item.openairecristypehttp://purl.org/coar/resource_type/c_18cf-
item.grantfulltextopen-
item.openairetypeartículo-
item.fulltextWith Fulltext-
item.languageiso639-1en-
Aparece en las colecciones: (CBM) Artículos
(CAB) Artículos
Ficheros en este ítem:
Fichero Descripción Tamaño Formato
AGrande-Pérez_PNAS_4448.pdf318,33 kBAdobe PDFVista previa
Visualizar/Abrir
Show simple item record

CORE Recommender

PubMed Central
Citations

91
checked on 09-abr-2024

SCOPUSTM   
Citations

153
checked on 20-abr-2024

WEB OF SCIENCETM
Citations

151
checked on 26-feb-2024

Page view(s)

373
checked on 24-abr-2024

Download(s)

194
checked on 24-abr-2024

Google ScholarTM

Check

Altmetric

Altmetric


Artículos relacionados:


NOTA: Los ítems de Digital.CSIC están protegidos por copyright, con todos los derechos reservados, a menos que se indique lo contrario.